Ardelyx
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 267
- Market Cap
- $1.4B
- Website
- http://www.ardelyx.com
- Introduction
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and d...
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 80
- Registration Number
- NCT02819687
Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2016-06-10
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 105
- Registration Number
- NCT02796131
A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
- Conditions
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 312
- Registration Number
- NCT02727751
- Locations
- 🇺🇸
Ardelyx Clinical Site, Miami, Florida, United States
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
- Conditions
- Interventions
- First Posted Date
- 2016-02-19
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 593
- Registration Number
- NCT02686138
- Locations
- 🇺🇸
Ardelyx Investigative Site 257, Dothan, Alabama, United States
🇺🇸Ardelyx Investigative Site 288, Miami, Florida, United States
🇺🇸Ardelyx Investigative Site 138, Atlanta, Georgia, United States
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 219
- Registration Number
- NCT02675998
- Locations
- 🇺🇸
Ardelyx Investigative Site 409, Brookhaven, Mississippi, United States
🇺🇸Ardelyx Investigative Site 402, Kalamazoo, Michigan, United States
🇺🇸Ardelyx Investigative Site 401, Saint George, Utah, United States
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
- Conditions
- Interventions
- First Posted Date
- 2015-12-04
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 606
- Registration Number
- NCT02621892
- Locations
- 🇺🇸
Ardelyx Investigative Site 137, Norcross, Georgia, United States
🇺🇸Ardelyx Investigative Site 278, Hagerstown, Maryland, United States
🇺🇸Ardelyx Investigative Site 135, Boston, Massachusetts, United States
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 16
- Registration Number
- NCT02346890
- Locations
- 🇺🇸
Healthcare Discoveries, LLC, San Antonio, Texas, United States
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2014-09-26
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 18
- Registration Number
- NCT02249936
- Locations
- 🇺🇸
ICON Development Solutions, Omaha, Nebraska, United States
D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2015-09-22
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 37
- Registration Number
- NCT02226783
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 83
- Registration Number
- NCT02176252
- Locations
- 🇺🇸
WCCT Global, Cypress, California, United States